Scisparc announces positive results from its weight loss and metabolic disorder program with its proprietary psychedelic-based treatment

The pre- clinical trial conducted using the combined treatment of scisparc's proprietary cannamide™ and clearmind medicine's meai molecule

SPRC Ratings Summary

SPRC Quant Ranking